FNYS
BMRN icon

First New York Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History

First New York Securities’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Hold
0
– – – 265
2016
Q2 		– Hold
0
– – – 225
2015
Q2 		– Sell
-2,000
Closed -$249K – 459
2015
Q1 		$249K Buy
+2,000
New +$212K 0.26% 55
2014
Q4 		– Sell
-500
Closed -$36.1K – 375
2014
Q3 		$36.1K Sell
500
-32,109
-98% -$2.11M 0.03% 286
2014
Q2 		$2.03M Buy
+32,609
New +$1.97M 2.43% 9
2013
Q3 		– Sell
-7,000
Closed -$390K – 363
2013
Q2 		$390K Buy
+7,000
New +$436K 0.23% 120

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return